Lazard Capital Upgrades Varian Medical (VAR) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P on track for muted open as Middle East tensions weigh; AI stocks boost Nasdaq
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal
- Piper Sandler Starts SoFi Technologies (SOFI) at Overweight
Brean Capital Starts Varian Medical (VAR) at Buy
October 26, 2012 8:25 AM EDTBrean Capital initiates coverage on Varian Medical (NYSE: VAR) with a Buy. PT $80.00.
The firm comments, "The company is the dominant player in the $5 billion radiation oncology market, with a 56% WW share (70% US). VAR is increasing its investments in emerging markets and proton therapy, both of which add... More
Varian Medical Systems (VAR) Tops Q4 EPS by 5c; Guides Q1, FY13
October 25, 2012 4:11 PM EDTVarian Medical Systems (NYSE: VAR) reported Q4 EPS of $1.08, $0.05 better than the analyst estimate of $1.03. Revenue for the quarter came in at $756.1 million versus the consensus estimate of $747.44 million.
Varian Medical Systems sees FY2013 EPS of $4.06-4.16, versus the consensus of $4.10.
... More
